Circulating Tumor Cell Burden as a Component of Staging in Multiple Myeloma: Ready for Prime Time?

被引：10
|
作者：
Chakraborty, Rajshekhar [1 ]
Lentzsch, Suzanne [1 ]
机构：
[1] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Multiple Myeloma & Amyloidosis Program, Irving Med Ctr, New York, NY 10032 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 27期
关键词：
PLASMA-CELLS; RISK STRATIFICATION; QUANTIFICATION; SURVIVAL;
D O I：
10.1200/JCO.22.01040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3099 / +
页数：5
相关论文
共 50 条
  • [41] Increase in circulating tumor cell burden during mobilization chemotherapy predicts for relapse after autologous transplantation in multiple myeloma patients.
    Vescio, R
    Stewart, A
    Ballester, O
    Noga, S
    Rugo, H
    Freytes, C
    Stadtmauer, E
    Kogut, N
    Tarantolo, S
    Stiff, P
    Pinero, L
    Dalton, W
    Ho, A
    Schiller, G
    Benyunes, M
    Jacobs, C
    Dipersio, J
    Anderson, K
    Berenson, J
    [J]. BLOOD, 1997, 90 (10) : 2515 - 2515
  • [42] Circulating tumor cells in metastatic breast cancer: Biologic staging beyond tumor burden
    Cristofanilli, Massimo
    Broglio, Kristine R.
    Guarneri, Valentina
    Jackson, Summer
    Fritsehe, Herbert A.
    Islam, Rabinl
    Dawood, Shaheenah
    Reuben, James M.
    Kau, Shu-Wan
    Lara, Juanita M.
    Krishnamurthy, Savitri
    Ueno, Naoto T.
    Hortobagyi, Gabriel N.
    Valero, Vicente
    [J]. CLINICAL BREAST CANCER, 2007, 7 (06) : 471 - 479
  • [43] Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?
    Heeke, Simon
    Hofman, Paul
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 631 - 638
  • [44] The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
    Mishima, Yuji
    Paiva, Bruno
    Shi, Jiantao
    Park, Jihye
    Manier, Salomon
    Takagi, Satoshi
    Massoud, Mira
    Perilla-Glen, Adriana
    Aljawai, Yosra
    Huynh, Daisy
    Roccaro, Aldo M.
    Sacco, Antonio
    Capelletti, Marzia
    Detappe, Alexandre
    Alignani, Diego
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    Prosper, Felipe
    Lohr, Jens G.
    Ha, Gavin
    Freeman, Samuel S.
    Van Allen, Eliezer M.
    Adalsteinsson, Viktor A.
    Michor, Franziska
    San Miguel, Jesus F.
    Ghobrial, Irene M.
    [J]. CELL REPORTS, 2017, 19 (01): : 218 - 224
  • [45] Targeted next-generation sequencing to assess tumor mutation burden: ready for prime-time in non-small cell lung cancer?
    Tomasini, Pascale
    Greillier, Laurent
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S323 - S326
  • [46] Circulating cell free DNA is a biomarker for GEP70 risk score and tumor burden in myeloma
    Deshpande, Shayu
    Wang, Yan
    Tytarenko, Ruslana
    Ashby, Cody
    Boyle, Eileen
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    Davies, Faith
    Morgan, Gareth
    van Rhee, Frits
    Walker, Brian
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E62 - E62
  • [47] Radiotherapy for Hepatocellular Carcinoma With Tumor Vascular Thrombus: Ready for Prime Time?
    Hong, Theodore S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (13) : 1619 - +
  • [48] Tumor-infiltrating T cells—ready for prime time in melanoma?
    Jason Chesney
    Kelly M. McMasters
    [J]. Nature Reviews Clinical Oncology, 2011, 8 : 449 - 450
  • [49] Tumor-Infiltrating Lymphocytes in Breast Cancer: Ready for Prime Time?
    Ocana, Alberto
    Diez-Gonzalez, Laura
    Adrover, Encarna
    Fernandez-Aramburo, Antonio
    Pandiella, Atanasio
    Amir, Eitan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1298 - +
  • [50] Is Stem Cell Transplantation Ready for Prime Time in Diabetic Polyneuropathy?
    Hiroki Mizukami
    Soroku Yagihashi
    [J]. Current Diabetes Reports, 2016, 16
12345